BioPredictive Overview
Company Headquarters: Paris, France
Founded: 1888
Company Working: BioPredictive is a biopharmaceutical company involved in designing and marketing a wide variety of non-invasive diagnostic tests for liver diseases. The company offers diagnostic tests such as FibroMax, Elasto-FibroTest, and HCV-GenoFibroTest. Its flagship product is the Elasto-FibroTest, which is the first diagnostic test for the liver that combines the results of the FibroTest- ActiTest for the determination of the level of necroinflammatory activity with an elastography result, directly from the user’s smartphone. The company has distribution channels throughout the world.
Strategy
BioPredictive actively participates in hepatology conferences in order to continuously incorporate innovative solutions in its products. The company focuses on designing its products in such a way as to offer a high-quality service with complete safety to its customers. Furthermore, the company strategizes to expand its geographic reach to increase its growth rate in the global NASH biomarkers market.
